Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Mounjaro expanded to include weight management The TGA has approved tirzepatide for the treatment of overweight and obesity for those with comorbidities, via private prescription.
‘I couldn’t walk’: GP’s personal story of vitamin B6 toxicity Found in listed medicines, energy drinks, cereals and weight loss shakes, some people are consuming more than 50x the recommended daily intake.
Concerns over growing misuse of Rikodeine cough medicine The addictive cough suppressant is popular among young people, more potent than codeine, and poses a serious risk of harm.
Mounjaro expanded to include weight management The TGA has approved tirzepatide for the treatment of overweight and obesity for those with comorbidities, via private prescription.
What does clutter do to your brain and body? An expert in organisational behaviour examines the effects disorganisation.
What is Ryeqo? While the medicine has already been available in Australia since 2022, it was recently approved for the treatment of endometriosis.
‘I couldn’t walk’: GP’s personal story of vitamin B6 toxicity Found in listed medicines, energy drinks, cereals and weight loss shakes, some people are consuming more than 50x the recommended daily intake.
Should Australia be worried about HMPV? As cases of human metapneumovirus surge overseas, what do Australian GPs need to know when concerned patients walk through their door?